Bowen Hanes & Co Inc’s Vertex Pharmaceuticals Inc Position
Does Bowen Hanes & Co Inc own Vertex Pharmaceuticals Inc (VRTX)? Yes — 135.4K shares worth $60M (+1.47% of its 13F portfolio) as of Q1 2026, up from 133.5K shares the prior filed quarter.
Position Value
$60M
Q1 2026
Shares
135.4K
% of Portfolio
+1.47%
Quarters Held
30
currently held
Position History VRTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 135.4K | $60M | +1.47% |
| Q4 2025 | 133.5K | $60,525 | +1.52% |
| Q3 2025 | 124.4K | $49M | +1.22% |
| Q2 2025 | 180.8K | $80M | +2.03% |
| Q1 2025 | 178.9K | $87M | +2.41% |
| Q4 2024 | 180.6K | $73M | +1.95% |
| Q3 2024 | 178.9K | $83M | +2.18% |
| Q2 2024 | 179.5K | $84M | +2.33% |
| Q1 2024 | 177.8K | $74,311 | +2.12% |
| Q4 2023 | 173.8K | $71M | +2.13% |
| Q3 2023 | 175.4K | $61M | +2.05% |
| Q2 2023 | 173.3K | $61M | +1.95% |
| Q1 2023 | 174.9K | $55M | +1.89% |
| Q4 2022 | 175.2K | $51M | +1.79% |
| Q3 2022 | 181.0K | $52M | +2.03% |
| Q2 2022 | 191.5K | $54M | +1.96% |
| Q1 2022 | 192.6K | $50M | +1.50% |
| Q4 2021 | 194.1K | $43M | +1.20% |
| Q3 2021 | 178.6K | $32M | +1.00% |
| Q2 2021 | 150.0K | $30M | +0.92% |
| Q1 2021 | 262.0K | $56M | +0.92% |
| Q4 2020 | 131.0K | $31M | +1.03% |
| Q3 2020 | 131.0K | $36M | +1.34% |
| Q2 2020 | 131.0K | $38M | +1.60% |
| Q1 2020 | 135.0K | $32M | +1.61% |
| Q4 2019 | 135.0K | $30M | +1.22% |
| Q3 2019 | 150.0K | $25M | +1.08% |
| Q2 2019 | 150.0K | $28M | +1.18% |
| Q1 2019 | 150.0K | $28M | +1.22% |
| Q4 2018 | 150.0K | $25M | +1.25% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bowen Hanes & Co Inc’s full portfolio or all institutional holders of VRTX.